(0.31%) 5 115.93 points
(0.31%) 38 358 points
(0.37%) 15 987 points
(-0.97%) $83.04
(5.36%) $2.03
(0.32%) $2 354.80
(0.54%) $27.68
(4.27%) $961.50
(-0.27%) $0.932
(-0.45%) $10.98
(-0.59%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States...
Stats | |
---|---|
Šios dienos apimtis | 24 877.00 |
Vidutinė apimtis | 33 975.00 |
Rinkos kapitalizacija | 5.63M |
EPS | $0 ( 2024-04-02 ) |
Kita pelno data | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.400 |
ATR14 | $0.0300 (2.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | St. Clair Gregory Sr | Buy | 3 268 | Common Stock |
2024-04-05 | Hawryluk Matthew | Buy | 2 368 | Common Stock |
2024-04-05 | Rao Veena | Buy | 3 268 | Common Stock |
2024-04-05 | Nuzum Charles Lee Sr | Buy | 3 268 | Common Stock |
2024-04-05 | Handley Daniel E | Buy | 2 353 | Common Stock |
INSIDER POWER |
---|
96.90 |
Last 95 transactions |
Buy: 2 153 627 | Sell: 54 044 |
Tūris Koreliacija
Predictive Oncology Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
RPAY | 0.829 |
VNQI | 0.828 |
LDEM | 0.826 |
SLQD | 0.823 |
IGSB | 0.823 |
SKOR | 0.823 |
IGIB | 0.817 |
SBUX | 0.815 |
GTH | 0.815 |
RGLD | 0.815 |
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Predictive Oncology Inc Koreliacija - Valiuta/Žaliavos
Predictive Oncology Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $1.78M |
Bruto pelnas: | $433 407 (24.35 %) |
EPS: | $-3.48 |
FY | 2023 |
Pajamos: | $1.78M |
Bruto pelnas: | $433 407 (24.35 %) |
EPS: | $-3.48 |
FY | 2022 |
Pajamos: | $1.51M |
Bruto pelnas: | $1.00M (66.45 %) |
EPS: | $-9.92 |
FY | 2021 |
Pajamos: | $1.42M |
Bruto pelnas: | $933 656 (65.72 %) |
EPS: | $-1.645 |
Financial Reports:
No articles found.
Predictive Oncology Inc
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.